<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: There is increasing awareness of <z:hpo ids='HP_0000135'>hypogonadism</z:hpo> in men with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> but limited data from Primary Care </plain></SENT>
<SENT sid="1" pm="."><plain>SUBJECTS AND METHODS: The anonymised records of 6457 male patients aged 18-80 years with <z:mp ids='MP_0002055'>diabetes</z:mp> were accessed </plain></SENT>
<SENT sid="2" pm="."><plain>Within the last 2 years 391 men (6.0% of total) underwent measurement of serum <z:chebi fb="51" ids="17347">testosterone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Data search was performed through the centralised data facility afforded by EMISÂ®, the majority GP systems provider in Cheshire </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: 4.4% of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> men screened were frankly hypogonadal with a serum total <z:chebi fb="51" ids="17347">testosterone</z:chebi> of less than 8.0 nmol/l </plain></SENT>
<SENT sid="5" pm="."><plain>For borderline <z:hpo ids='HP_0000135'>hypogonadism</z:hpo> (serum total <z:chebi fb="51" ids="17347">testosterone</z:chebi> 8-11.99 nmol/l) the proportion of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> men rose to 32.1% </plain></SENT>
<SENT sid="6" pm="."><plain>Age adjusted mean (geometric) <z:chebi fb="51" ids="17347">testosterone</z:chebi> was lower in men with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (13.6 nmol/l 95%CI: 13.1-14.2) vs type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (17.9 nmol/l; 95%CI 15.2-21.0), F=10.3; p=0.0014 </plain></SENT>
<SENT sid="7" pm="."><plain>For those screened age adjusted body mass index (BMI) was greater in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> at 30.7 (30.1-31.3) vs 28.4 (26.1-30.6)kg/m(2) in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (F=4.3; p=0.04) </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple linear regression analysis indicated that there was a statistically significant interaction (P=0.014) between BMI and <z:mp ids='MP_0002055'>diabetes</z:mp> type in their relation with log <z:chebi fb="51" ids="17347">testosterone</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>For persons with type 1 DM and type 2 DM, <z:chebi fb="51" ids="17347">testosterone</z:chebi> can be expected to decrease by 6% (P=0.002) and by 1% (P=0.002) respectively, for every one unit increment in BMI </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: There is manifestly a subset of men with <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:chebi fb="3" ids="50113">androgen</z:chebi> deficiency who could benefit from <z:chebi fb="51" ids="17347">testosterone</z:chebi> replacement </plain></SENT>
<SENT sid="11" pm="."><plain>BMI has an independent influence on <z:chebi fb="3" ids="50113">androgen</z:chebi> status </plain></SENT>
</text></document>